This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs) targeting neurological and cardiovascular disorders. Its structure, featuring a tetrahydronaphthalene moiety, makes it a valuable intermediate in the production of compounds that interact with adrenergic and serotonin receptors. It is also explored for its potential in creating drugs for treating conditions like hypertension, depression, and anxiety due to its ability to modulate neurotransmitter systems. Additionally, it may serve as a chiral building block in asymmetric synthesis, contributing to the development of enantiomerically pure drugs.